Immuron

+$0.11 (+3.06%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immuron and other ETFs, options, and stocks.

About IMRN

Immuron Ltd. engages in the research and development of oral immunotherapy, and product sales which focuses on bovine-colostrum with antibodies of choice for the treatment and prevention of a range of infectious and immune modulated diseases. It operates through the following segments: Research and Development, and HyperImmune Products.The Research and Development segment involves the R&D projects performed in Australia, Israel, and United States.

CEO
Jerry Kanellos
Employees
—
Headquarters
Carlton, Victoria (VIC)
Founded
1994

IMRN Key Statistics

Market cap
21.13M
Price-Earnings ratio
—
Dividend yield
—
Average volume
5.14M
High today
$3.72
Low today
$3.36
Open price
$3.36
Volume
434.35K
52 Week high
$9.23
52 Week low
$2.32

IMRN News

Simply Wall StJan 21

We Think Immuron Can Afford To Drive Business Growth

We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money

IMRN Earnings

Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Feb 23, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure